TGFB1 and Hepatic fibrosis: Accumulating evidence suggest that divergent miRNAs participates in the liver fibrotic process, which partially regulates members of the TGF-β/SMAD signaling pathway, which address the possibility of novel therapeutic approaches to hepatic fibrosis [18].